XML 37 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue (Tables)
3 Months Ended
Jan. 31, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table presents the company’s segment revenue disaggregated by geographical region and the company’s total revenue disaggregated by end markets and by revenue type (in millions):
 
Three Months Ended January 31, 2019
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Revenue by Region
 
 
 
 
 
 
 
Americas
$
168

 
$
109

 
$
156

 
$
433

Europe
164

 
91

 
128

 
383

Asia Pacific
275

 
35

 
158

 
468

Total
$
607

 
$
235

 
$
442

 
$
1,284

 
 
 
 
 
 
 
 
Revenue by End Markets
 
 
 
 
 
 
 
Pharmaceutical and Biotechnology
 
 
 
 
 
 
$
391

Chemical and Energy
 
 
 
 
 
 
308

Diagnostics and Clinical
 
 
 
 
 
 
187

Food
 
 
 
 
 
 
129

Academia and Government
 
 
 
 
 
 
116

Environmental and Forensics
 
 
 
 
 
 
153

Total
 
 
 
 
 
 
$
1,284

 
 
 
 
 
 
 
 
Revenue by Type
 
 
 
 
 
 
 
Instrumentation
 
 
 
 
 
 
$
567

Non-instrumentation and other
 
 
 
 
 
 
717

Total
 
 
 
 
 
 
$
1,284

Contract Liabilities and Changes in Balances
The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the three months ended January 31, 2019:

 
 
Contract
Liabilities
 
 
(in millions)
 
 
 
Ending balance as of October 31, 2018
 
$
367

Impact of adoption of new revenue recognition guidance
 
(11
)
Net revenue deferred in the period
 
148

Revenue recognized that was included in the contract liability balance at the beginning of the period
 
(125
)
Change in deferrals from customer cash advances, net of revenue recognized
 
8

Contract liabilities acquired in business combinations
 
2

Currency translation and other adjustments
 
4

Ending balance as of January 31, 2019
 
$
393